MEHTA VIMAL (CEO, President, Secretary) exercised options at BIOXCEL THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/18/2026ACC: 0001104659-26-075298
DirectorOfficer· CEO, President, Secretary
Since Nov 2018
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
219.00 acquired · 219.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+219.00
Price / share
—
Trade value
—
% of position
0.3%
6/15/2026
69.60K→69.82K
Total
Net shares
+219.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2026 | M · Option Exercise | +219.00 | — | — | 0.3% | 69.60K | 69.82K |
| Total | +219.00 | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
219.00 shares
Shares
−219.00
Strike price
Held after
1.31K
Exercisable
—
6/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock219.00 shares | 6/15/2026 | M · Option Exercise | −219.00 | — | 1.31K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned125.00
Common Stock
IndirectShares owned480.34K
Total
480.47K indirect480.47K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 125.00 | Indirect |
| Common Stock | 480.34K | Indirect |
| Total | 480.47K | 480.47K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported